A real-world study of grass-pollen SLIT tablets in controlling allergic rhinitis

Trial Profile

A real-world study of grass-pollen SLIT tablets in controlling allergic rhinitis

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Jun 2017

At a glance

  • Drugs Grass pollen allergy immunotherapy (Primary)
  • Indications Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Jun 2017 New trial record
    • 19 Jun 2017 Results from this trial have been published in the journal Allergy and were presented at the annual European Academy of Allergy and Clinical Immunology (EAACI) Congress.
    • 19 Jun 2017 Results published in a Stallergenes Greer media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top